Cargando…
Artificial Intelligence in Lung Cancer Imaging: Unfolding the Future
Lung cancer is one of the malignancies with higher morbidity and mortality. Imaging plays an essential role in each phase of lung cancer management, from detection to assessment of response to treatment. The development of imaging-based artificial intelligence (AI) models has the potential to play a...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9689810/ https://www.ncbi.nlm.nih.gov/pubmed/36359485 http://dx.doi.org/10.3390/diagnostics12112644 |
_version_ | 1784836628321140736 |
---|---|
author | Cellina, Michaela Cè, Maurizio Irmici, Giovanni Ascenti, Velio Khenkina, Natallia Toto-Brocchi, Marco Martinenghi, Carlo Papa, Sergio Carrafiello, Gianpaolo |
author_facet | Cellina, Michaela Cè, Maurizio Irmici, Giovanni Ascenti, Velio Khenkina, Natallia Toto-Brocchi, Marco Martinenghi, Carlo Papa, Sergio Carrafiello, Gianpaolo |
author_sort | Cellina, Michaela |
collection | PubMed |
description | Lung cancer is one of the malignancies with higher morbidity and mortality. Imaging plays an essential role in each phase of lung cancer management, from detection to assessment of response to treatment. The development of imaging-based artificial intelligence (AI) models has the potential to play a key role in early detection and customized treatment planning. Computer-aided detection of lung nodules in screening programs has revolutionized the early detection of the disease. Moreover, the possibility to use AI approaches to identify patients at risk of developing lung cancer during their life can help a more targeted screening program. The combination of imaging features and clinical and laboratory data through AI models is giving promising results in the prediction of patients’ outcomes, response to specific therapies, and risk for toxic reaction development. In this review, we provide an overview of the main imaging AI-based tools in lung cancer imaging, including automated lesion detection, characterization, segmentation, prediction of outcome, and treatment response to provide radiologists and clinicians with the foundation for these applications in a clinical scenario. |
format | Online Article Text |
id | pubmed-9689810 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-96898102022-11-25 Artificial Intelligence in Lung Cancer Imaging: Unfolding the Future Cellina, Michaela Cè, Maurizio Irmici, Giovanni Ascenti, Velio Khenkina, Natallia Toto-Brocchi, Marco Martinenghi, Carlo Papa, Sergio Carrafiello, Gianpaolo Diagnostics (Basel) Review Lung cancer is one of the malignancies with higher morbidity and mortality. Imaging plays an essential role in each phase of lung cancer management, from detection to assessment of response to treatment. The development of imaging-based artificial intelligence (AI) models has the potential to play a key role in early detection and customized treatment planning. Computer-aided detection of lung nodules in screening programs has revolutionized the early detection of the disease. Moreover, the possibility to use AI approaches to identify patients at risk of developing lung cancer during their life can help a more targeted screening program. The combination of imaging features and clinical and laboratory data through AI models is giving promising results in the prediction of patients’ outcomes, response to specific therapies, and risk for toxic reaction development. In this review, we provide an overview of the main imaging AI-based tools in lung cancer imaging, including automated lesion detection, characterization, segmentation, prediction of outcome, and treatment response to provide radiologists and clinicians with the foundation for these applications in a clinical scenario. MDPI 2022-10-31 /pmc/articles/PMC9689810/ /pubmed/36359485 http://dx.doi.org/10.3390/diagnostics12112644 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Cellina, Michaela Cè, Maurizio Irmici, Giovanni Ascenti, Velio Khenkina, Natallia Toto-Brocchi, Marco Martinenghi, Carlo Papa, Sergio Carrafiello, Gianpaolo Artificial Intelligence in Lung Cancer Imaging: Unfolding the Future |
title | Artificial Intelligence in Lung Cancer Imaging: Unfolding the Future |
title_full | Artificial Intelligence in Lung Cancer Imaging: Unfolding the Future |
title_fullStr | Artificial Intelligence in Lung Cancer Imaging: Unfolding the Future |
title_full_unstemmed | Artificial Intelligence in Lung Cancer Imaging: Unfolding the Future |
title_short | Artificial Intelligence in Lung Cancer Imaging: Unfolding the Future |
title_sort | artificial intelligence in lung cancer imaging: unfolding the future |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9689810/ https://www.ncbi.nlm.nih.gov/pubmed/36359485 http://dx.doi.org/10.3390/diagnostics12112644 |
work_keys_str_mv | AT cellinamichaela artificialintelligenceinlungcancerimagingunfoldingthefuture AT cemaurizio artificialintelligenceinlungcancerimagingunfoldingthefuture AT irmicigiovanni artificialintelligenceinlungcancerimagingunfoldingthefuture AT ascentivelio artificialintelligenceinlungcancerimagingunfoldingthefuture AT khenkinanatallia artificialintelligenceinlungcancerimagingunfoldingthefuture AT totobrocchimarco artificialintelligenceinlungcancerimagingunfoldingthefuture AT martinenghicarlo artificialintelligenceinlungcancerimagingunfoldingthefuture AT papasergio artificialintelligenceinlungcancerimagingunfoldingthefuture AT carrafiellogianpaolo artificialintelligenceinlungcancerimagingunfoldingthefuture |